Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
During research, scientists often choose BPC-157 500MCG to examine how it reacts to shifts in heat, pH, or other controlled settings
Its short half-life, however, required it to be injected several times a day, which limited its appeal as a drug, and the company ran out of funding
Researchers examined BPC-157s effects on melanoma cells in vitro and found something unexpected: the peptide inhibited melanoma cell proliferation rather than promoting it
Continuous administration does not seem to provide additional benefit and may actually diminish the compound's effectiveness over time
Dizziness: Occasionally reported, possibly related to blood pressure effects
US$ 28.35
US$ 20.04
US$ 21.50
US$ 22.81
